Making Sense of Rising Oncology Drug Costs

Mark Shapiro is the Vice President of Clinical Development at Clinipace. Although cost control for drugs has been common in countries with socialized medicine or government-payer systems, this issue is now beginning to take center stage here in the United States. ...